Novartis CEO Vas Narasimhan talks with CNBC about the Swiss pharmaceutical company’s second-quarter earnings, forward guidance and patent expiries.
Novartis CEO on Q2 earnings beat and patent expiries
Related posts
-
Rep. Veasey Calls for Scrutiny of Trump Russia Ties
Bloomberg TelevisionMon, October 19, 2026 4:43amURL:Embed:Rep. Marc Veasey, a Texas Democrat, tells Bloomberg This Weekend that... -
Asian Chip Stocks Extend Losses
Bloomberg TelevisionMon, October 19, 2026 4:43amURL:Embed:“Bloomberg: The Asia Trade” brings you everything you need to know... -
Sylvester Stallone says the real acting went to streaming. 🎬 🎥
Yahoo FinanceMon, October 19, 2026 4:43amURL:Embed:Sylvester Stallone says the real acting went to streaming. 🎬 🎥...